NCT04225390 2026-02-10
PROMIT
University of Erlangen-NĂŒrnberg Medical School
Phase 2 Completed
Clinical Trials
13 trialsNCT07191405 2025-09-24
Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT07155811 2025-09-04
T-ECHNICO
Centre Leon Berard
Phase NA Not yet recruiting
NCT05909137 2025-07-14
Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Xinqiao Hospital of Chongqing
Not yet recruiting
NCT06946745 2025-04-27
Exploration of the Dynamic Changes and Mechanisms of the Immune Microenvironment in Advanced Colorectal Cancer Treated With IBI363 Combination Therapy
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Recruiting
NCT05223088 2025-03-18
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IVăLarge Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT06276088 2024-03-15
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
Nanfang Hospital, Southern Medical University
Recruiting
NCT04169841 2024-02-13
GUIDE2REPAIR
Centre Georges Francois Leclerc
Phase 2 Active not recruiting
NCT05479240 2023-06-18
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05719324 2023-02-10
Checkpoint Inhibitors in Patients With Solid Tumors: a Retrospective Real-world Study
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05354375 2022-04-29
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 1 Recruiting
NCT04587817 2020-10-14
Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors
Peking University First Hospital
Unknown
NCT03619954 2018-08-08
NK Cells Infusion for Advanced Malignancies
Anhui Provincial Hospital
Phase 1 Unknown